Jamkas Pharmaceuticals Strengthens Healthcare in J&K with ₹16 Crore Project

Jamkas Pharmaceuticals Private Limited is poised to make a significant impact with its IE Tablets, Capsules, Dry Syrup, and Dry Injection Project in Ghatti, Kathua, Jammu & Kashmir. Valued at 16 crores, this venture marks a substantial investment in pharmaceutical manufacturing infrastructure. Spanning an area of 1 acre, the project aims to address the growing demand for essential medicines in the region.

The establishment of the IE Tablets, Capsules, Dry Syrup, and Dry Injection Project underscores Jamkas Pharmaceuticals' commitment to providing high-quality pharmaceutical products to consumers. By producing a diverse range of medications, including tablets, capsules, syrups, and injections, the company aims to cater to the healthcare needs of the local community and beyond. This initiative is expected to enhance access to essential medicines and contribute to improving public health outcomes in Jammu & Kashmir.

The project holds promise for stimulating economic development and employment generation in Ghatti, Kathua, and the wider Jammu & Kashmir region. By establishing pharmaceutical manufacturing facilities in the area, Jamkas Pharmaceuticals Private Limited is creating job opportunities and supporting local livelihoods. This aligns with broader efforts to promote socio-economic growth and prosperity in the region.

News by Rahul Yelligetti